Monitoring-Based Model for Personalizing the Clinical Process of Crohn's Disease

Alberto de Ramón-Fernández1, Daniel Ruiz-Fernández2, Diego Marcos-Jorquera3

  • 1Department of Computer Technology, University of Alicante, Alicante 03690, Spain. aderamon@dtic.ua.es.

Insights

This study introduces a technological model for personalized Crohn's disease management. Continuous patient monitoring and AI analysis aim to tailor treatments for better clinical outcomes in inflammatory bowel disease.

Area of Science:

  • Gastroenterology
  • Biomedical Engineering
  • Health Informatics

Background:

  • Crohn's disease is a chronic inflammatory bowel disease requiring lifelong medical supervision.
  • Individual patient characteristics necessitate personalized treatment and health recommendations.
  • Current management approaches often lack cost-effective personalization.

Purpose of the Study:

  • To propose a technology-based model for personalized Crohn's disease management.
  • To develop a system architecture and prototype for functional validation.
  • To leverage continuous monitoring and AI for tailored clinical processes.

Main Methods:

  • Development of an information flow model (control, personalization, monitoring).
  • Design of a service-based architecture and system prototype.
  • Integration of diverse monitoring devices and AI algorithms for data analysis.

Main Results:

  • A functional prototype integrating patient and environmental monitoring technologies was created.
  • Artificial intelligence algorithms were incorporated to streamline data review and analysis.
  • The system facilitates continuous and automated monitoring of Crohn's disease patients.

Conclusions:

  • The proposed model enables personalized Crohn's disease management through continuous monitoring.
  • AI-driven analysis reduces the burden of data interpretation.
  • This approach supports the individualization of clinical processes for Crohn's patients.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
455
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
652
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
980